ARCUTIS BIOTHERAPEUTICS INC (ARQT:NASDAQ)
$28.49 0.75 (2.7037%)
Analysed ARCUTIS BIOTHERAPEUTICS INC (ARQT:NASDAQ) News Sources
Arcutis Director Sells $121,000 in Stock as ZORYVE Revenue Jumps 65%
23-06-2026
fool.com
FDA Approves Arcutis’ ZORYVE® (roflumilast) Cream 0.3% for the Treatment of Plaque Psoriasis in Children as Young as Age 2
29-06-2026
yahoo.com
Arcutis Launches New Virtual Health Platform Supporting Access to Care for Individuals Living with Chronic Inflammatory Skin Diseases, Including Approved ZORYVE® (roflumilast) Indications
30-06-2026
yahoo.com
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02-07-2026
yahoo.com
Arcutis vs. Vertex: Which Pharmaceutical Maker Stock Is a Better Buy in 2026?
03-07-2026
fool.com
FDA Accepts Supplemental New Drug Application for Arcutis’ ZORYVE® (roflumilast) Cream 0.05% for the Treatment of Mild to Moderate Atopic Dermatitis in Infants Down to 3 Months
08-07-2026
yahoo.com
Biotech Stock Arcutis Climbs Into Buy Zone As FDA Mulls Expanded Use For Key Skin Treatment
09-07-2026
yahoo.com
Attovia Therapeutics Appoints John W. Smither to Board of Directors
15-07-2026
yahoo.com
Arcutis to Report Second Quarter 2026 Financial Results and Host Conference Call on August 5, 2026
15-07-2026
yahoo.com
Arcutis Expands Board of Directors with Appointment of Chris Peetz
16-07-2026
yahoo.com
What is the current price of ARCUTIS BIOTHERAPEUTICS INC (ARQT:NASDAQ)?
The current price of ARCUTIS BIOTHERAPEUTICS INC (ARQT:NASDAQ) is $28.49.
ARCUTIS BIOTHERAPEUTICS INC (ARQT:NASDAQ) absolute price change since previous trading day?
The absolute price change of ARCUTIS BIOTHERAPEUTICS INC (ARQT:NASDAQ) since the previous trading day is $0.75.
ARCUTIS BIOTHERAPEUTICS INC (ARQT:NASDAQ) percentage price change since previous trading day?
The percentage price change of ARCUTIS BIOTHERAPEUTICS INC (ARQT:NASDAQ) since the previous trading day is 2.7037%.
What is the most recent average sentiment score for ARCUTIS BIOTHERAPEUTICS INC (ARQT:NASDAQ)?
The most recent average sentiment score for ARCUTIS BIOTHERAPEUTICS INC (ARQT:NASDAQ) is 80 out of 100.
What is the most recent average sentiment for ARCUTIS BIOTHERAPEUTICS INC (ARQT:NASDAQ)?
The most recent sentiment for ARCUTIS BIOTHERAPEUTICS INC (ARQT:NASDAQ) is .
SEC-8K** Filing Available For ARCUTIS BIOTHERAPEUTICS INC (ARQT:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.